9.3. Analysis.
Comparison 9 HUS studies: Shiga toxin binding agent plus supportive therapy versus placebo plus supportive care, Outcome 3 Proteinuria ≥ 2 at last follow‐up (60 days).
Comparison 9 HUS studies: Shiga toxin binding agent plus supportive therapy versus placebo plus supportive care, Outcome 3 Proteinuria ≥ 2 at last follow‐up (60 days).